Analysis on the Theory and Practice of Centralized Volume-Based Drug Procurement System in China
In China,the centralized volume-based procurement of drugs is a system innovation that leverages the strategic purchasing function of healthcare insurance,to reconstruct the pharmaceutical price formation mechanism,standardize the order of drug circulation,reduce the burden of patients'drug costs,and ensure rationality and safety of drug use.This study aims to systematically review the policy connotations,operational effects,and multi-influences from the perspective of system establishment.The core mechanism includes the working mechanism of government organization,alliance procurement,and platform operation,the rule mechanism of giving priority to drug quality,guaranteeing supply and procurement based on clinical needs,as well as the operation and maintenance mechanism of centralized procurement and use.The core drug price formation mechanism includes the market exchange mechanism of"price for volume"and market contract mechanism of"four guarantees".The implementation of the system involves 4 key links(bidding procurement,supply and delivery,distribution and use,and continuation work)and 18 core elements.After the implementation of the centralized volume-based procurement policy,there were obvious clinical substitution effects of drug use,improvement in drug accessibility,significant decrease in drug costs which mainly benefits patients,increase in drug market concentration,and gradual reshaping of the industrial pattern.
centralized volume-based drug procurement systemprice formation mechanismpolicy effect
万方数据
维普
